查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1828873

非小细胞肺癌 (NSCLC) 市场分析与预测（至 2034 年）按类型、产品、技术、应用、最终用户、阶段、设备、解决方案和流程

Non-Small Cell Lung Cancer (NSCLC) Market Analysis and Forecast to 2034: Type, Product, Technology, Application, End User, Stage, Device, Solutions, Process
出版日期: | 出版商: Global Insight Services | 英文 385 Pages | 商品交期: 3-5个工作天内

价格
简介目录

非小细胞肺癌 (NSCLC) 市场预计将从 2024 年的 195 亿美元扩大到 2034 年的 616 亿美元，复合年增长率约为 12.2%。非小细胞肺癌 (NSCLC) 市场包括针对最常见的肺癌类型 NSCLC 的治疗解决方案的开发、生产和分销。该市场的特点是创新治疗方法，例如标靶治疗和免疫疗法，旨在改善患者预后。在发病率上升和精准医疗进步的推动下，由于对研究和临床试验的大量投资，市场有望实现成长。主要趋势包括个人化医疗方法、联合治疗以及整合生物标记以提高治疗效果。

非小细胞肺癌 (NSCLC) 市场正经历强劲成长，主要得益于标靶治疗和免疫疗法的进步。目前，标靶治疗领域以 EGFR 抑制剂和 ALK 抑制剂为主导，由于它们对特定基因突变的有效性，它们表现最佳。免疫疗法，尤其是 PD-1 和 PD-L1 抑制剂，表现第二佳，反映出它们越来越多地被用作一线治疗。联合治疗势头强劲，提高了疗效并改善了患者预后。虽然化疗正在衰落，但它仍然占有重要地位，尤其是与其他治疗方法合併使用时。在基因组分析和生物标记识别进步的支持下，个人化医疗已成为关键趋势。这一趋势正在推动伴随诊断的创新和投资。在病患偏好和成本效益的推动下，门诊病人也出现了转变。持续的研究和开发工作预计将带来新的治疗选择，进一步推动市场成长。

细分市场
种类 腺癌、鳞状细胞癌、大细胞癌
产品 标靶治疗、免疫治疗、化疗和放射线治疗
科技 生物标记检测、基因检测、诊断影像技术、奈米技术
目的 一线治疗、第二线治疗、维持治疗、辅助治疗、新辅助治疗
最终用户 医院、癌症研究机构、专科诊所、製药公司
阶段 第一阶段、第二阶段、第三阶段、第四阶段
装置 切片检查设备、诊断影像设备、放射治疗设备
解决方案 病患管理、临床试验和药物开发
流程 药物发现、临床开发、监管核准和上市

市场概述

非小细胞肺癌 (NSCLC) 市场正经历动态变化，创新的定价策略和新型治疗药物的引入导致市场份额大幅波动。该市场的特点是不断推出旨在满足未满足医疗需求和改善患者预后的新型治疗药物。这些新进业者的竞争性定价正在重塑市场动态，并促进更广泛的可及性和应用。受当地法规结构和医疗政策的影响，各主要地区的定价趋势各不相同。随着製药公司继续专注于研发以保持竞争力，市场将进一步发展。竞争性基准基准化分析突显了老牌大型製药企业和新兴生物技术公司在 NSCLC 市场中的激烈竞争。监管影响起着关键作用，严格的核准流程影响新产品的推出速度。北美和欧洲在监管领域占据主导地位，为安全性和有效性设定了高标准。虽然这些地区在市场份额方面也处于领先地位，但由于对医疗基础设施的投资增加和患者人数的不断增长，亚太地区正逐渐成为关键参与者。策略联盟和合併进一步塑造了竞争格局。随着企业寻求加强其市场地位和扩大产品系列，此类联盟和合併变得越来越普遍。

主要趋势和驱动因素

在标靶治疗和免疫治疗的推动下，非小细胞肺癌 (NSCLC) 市场正在经历变革性成长。主要趋势包括个人化医疗方法的开发、治疗效果和患者预后的改善。人工智慧在诊断领域的整合正在加速早期发现和精准治疗计划，推动市场扩张。生物标记主导疗法的兴起也是一个关键趋势，它使得更个人化和有效的治疗方法成为可能。不断增加的研发投入正在刺激技术创新并创造新的治疗选择。 NSCLC 盛行率的上升，加上人口老化，大大推动了对先进治疗方案的需求。此外，监管支持和突破性疗法的快速核准流程正在促进其快速进入市场。医疗基础设施发达、肺癌意识日益增强的新兴市场提供了充足的商机。专注于策略伙伴关係和扩展产品平臺的公司能够充分利用这一充满活力的市场环境。

限制与挑战：

NSCLC 市场面临几个重大的限制和挑战。一个关键挑战是标靶治疗和免疫疗法的成本高昂，限制了低收入地区患者的治疗机会。这些先进的疗法通常价格过高，阻碍了其广泛采用并加剧了医疗保健的不公平性。此外，NSCLC 复杂的基因图谱需要个人化的治疗方法，并使治疗通讯协定的标准化变得复杂。这种复杂性也增加了医疗保健提供者的负担，使他们需要及时了解最新发展并相应地调整治疗方案。另一个挑战是与新治疗方法的核准相关的监管障碍，这可能会延迟市场进入并增加开发成本。此外，与 NSCLC 治疗相关的副作用可能很严重，影响患者的生活品质和治疗顺从性。最后，某些地区无法获得全面的基因组检测，这阻碍了精准医疗的有效实施并限制了最佳治疗效果。

主要企业

百济神、信达生物、再鼎医药、和记医药、Array BioPharma、Blueprint Medicines、Mirati Therapeutics、Turning Point Therapeutics、Iovance Biotherapeutics、MacroGenics、第一三共、Eisai、住友製药、中外製药、协和麒麟

目录

第 1 章非小细胞肺癌 (NSCLC) 市场概述

  • 分析目的
  • 非小细胞肺癌（NSCLC）市场定义和范围
  • 报告限制
  • 分析期和货币
  • 分析方法

第二章执行摘要

第三章 关键市场考量因素

第四章非小细胞肺癌（NSCLC）市场展望

  • 非小细胞肺癌（NSCLC）市场区隔
  • 市场动态
  • 波特五力分析
  • PESTLE分析
  • 价值链分析
  • 4P模型
  • 安索夫矩阵

第五章：非小细胞肺癌（NSCLC）市场策略

  • 母市场分析
  • 供需分析
  • 消费者购买意向
  • 案例研究分析
  • 定价分析
  • 监管状况
  • 供应链分析
  • 竞争分析
  • 近期动态

第六章 非小细胞肺癌（NSCLC）市场规模

  • 非小细胞肺癌（NSCLC）市场规模（以金额为准）
  • 非小细胞肺癌（NSCLC）市场规模（数量基础）

第七章非小细胞肺癌（NSCLC）市场：依类型

  • 市场概况
  • 腺癌
  • 鳞状细胞癌
  • 大细胞癌
  • 其他的

8. 非小细胞肺癌（NSCLC）市场（依产品）

  • 市场概况
  • 标靶治疗药物
  • 免疫疗法
  • 化疗药物
  • 放射线治疗
  • 其他的

9. 非小细胞肺癌（NSCLC）市场（依技术）

  • 市场概况
  • 生物标记检测
  • 基因检测
  • 诊断影像技术
  • 奈米科技
  • 其他的

第 10 章非小细胞肺癌 (NSCLC) 市场的应用

  • 市场概况
  • 一线治疗
  • 二线治疗
  • 维持治疗
  • 辅助治疗
  • 新辅助治疗
  • 其他的

第 11 章。非小细胞肺癌 (NSCLC) 市场（按最终用户）

  • 市场概况
  • 医院
  • 癌症研究所
  • 专科诊所
  • 製药公司
  • 其他的

第 12 章非小细胞肺癌 (NSCLC) 市场分阶段

  • 市场概况
  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段
  • 其他的

13. 非小细胞肺癌（NSCLC）市场（按设备）

  • 市场概况
  • 切片检查装置
  • 诊断影像设备
  • 放射治疗设备
  • 其他的

14. 非小细胞肺癌（NSCLC）市场（依解决方案）

  • 市场概况
  • 病人管理
  • 临床试验
  • 药物开发
  • 其他的

第 15 章非小细胞肺癌 (NSCLC) 市场（依流程）

  • 市场概况
  • 药物研发
  • 临床开发
  • 药品核准
  • 上市
  • 其他的

16. 非小细胞肺癌（NSCLC）市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 瑞典
    • 瑞士
    • 丹麦
    • 芬兰
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 新加坡
    • 印尼
    • 台湾
    • 马来西亚
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 其他中东和非洲地区

第十七章竞争格局

  • 概述
  • 市占率分析
  • 主要企业定位
  • 衝突领导地图
  • 供应商基准化分析
  • 发展策略基准化分析

第十八章：公司简介

  • BeiGene
  • Innovent Biologics
  • Zai Lab
  • Hutchmed
  • Array BioPharma
  • Blueprint Medicines
  • Mirati Therapeutics
  • Turning Point Therapeutics
  • Iovance Biotherapeutics
  • MacroGenics
  • Daiichi Sankyo
  • Eisai
  • Sumitomo Dainippon Pharma
  • Chugai Pharmaceutical
  • Kyowa Kirin
简介目录
Product Code: GIS34093

Non-Small Cell Lung Cancer (NSCLC) Market is anticipated to expand from $19.5 billion in 2024 to $61.6 billion by 2034, growing at a CAGR of approximately 12.2%. The Non-Small Cell Lung Cancer (NSCLC) Market encompasses the development, production, and distribution of therapeutic solutions targeting NSCLC, the most prevalent form of lung cancer. This market is characterized by innovative treatments, including targeted therapies and immunotherapies, aimed at improving patient outcomes. Driven by rising incidence rates and advancements in precision medicine, the market is poised for growth, with significant investment in research and clinical trials. Key trends include personalized medicine approaches, combination therapies, and the integration of biomarkers for enhanced treatment efficacy.

The Non-Small Cell Lung Cancer (NSCLC) Market is experiencing robust growth, primarily driven by advancements in targeted therapies and immunotherapies. The targeted therapy segment is currently the top-performing, with EGFR inhibitors and ALK inhibitors leading due to their efficacy in specific genetic mutations. Immunotherapy, particularly PD-1 and PD-L1 inhibitors, is the second highest-performing segment, reflecting its increasing adoption as a first-line treatment. Combination therapies are gaining momentum, offering enhanced efficacy and improved patient outcomes. The chemotherapy segment, while declining, remains relevant, especially in combination with other modalities. Personalized medicine is emerging as a key trend, supported by advancements in genomic profiling and biomarker identification. This trend is driving innovation and investment in companion diagnostics. The market is also witnessing a shift towards outpatient settings, influenced by patient preference and cost efficiency. Continuous research and development efforts are expected to yield novel treatment options, further propelling market growth.

Market Segmentation
TypeAdenocarcinoma, Squamous Cell Carcinoma, Large Cell Carcinoma
ProductTargeted Therapy Drugs, Immunotherapy Drugs, Chemotherapy Drugs, Radiotherapy
TechnologyBiomarker Testing, Genetic Testing, Imaging Technologies, Nanotechnology
ApplicationFirst-Line Treatment, Second-Line Treatment, Maintenance Therapy, Adjuvant Therapy, Neoadjuvant Therapy
End UserHospitals, Cancer Research Institutes, Specialty Clinics, Pharmaceutical Companies
StageStage I, Stage II, Stage III, Stage IV
DeviceBiopsy Devices, Diagnostic Imaging Systems, Radiotherapy Equipment
SolutionsPatient Management, Clinical Trials, Drug Development
ProcessDrug Discovery, Clinical Development, Regulatory Approval, Commercialization

Market Snapshot:

The Non-Small Cell Lung Cancer (NSCLC) market is witnessing dynamic changes, with significant shifts in market share driven by innovative pricing strategies and the introduction of new therapeutic products. The landscape is characterized by the launch of novel treatments that aim to address unmet medical needs, thereby enhancing patient outcomes. The competitive pricing of these new entrants is reshaping the market dynamics, encouraging broader accessibility and adoption. Key regions are experiencing varied pricing trends, influenced by local regulatory frameworks and healthcare policies. The market is poised for further evolution as pharmaceutical companies continue to focus on research and development to maintain a competitive edge. In terms of competition benchmarking, the NSCLC market is marked by intense rivalry among established pharmaceutical giants and emerging biotech firms. Regulatory influences play a pivotal role, with stringent approval processes impacting the pace of new product introductions. North America and Europe dominate the regulatory landscape, setting high standards for safety and efficacy. These regions also lead in terms of market share, yet Asia-Pacific is emerging as a significant player due to increased investment in healthcare infrastructure and a growing patient population. The competitive landscape is further shaped by strategic alliances and mergers, which are becoming increasingly common as companies seek to enhance their market position and expand their product portfolios.

Geographical Overview:

The NSCLC market is witnessing robust growth across diverse regions, each exhibiting unique characteristics. North America remains a dominant force, driven by advanced healthcare infrastructure and significant R&D investments. The region's focus on innovative therapies and precision medicine is fostering market expansion. Europe follows closely, with strong governmental support and a rising prevalence of lung cancer contributing to market dynamics. The Asia Pacific region is experiencing rapid growth, propelled by increased healthcare spending and a burgeoning population. Countries like China and India are emerging as key players, with large patient pools and improving healthcare access. Latin America and the Middle East & Africa are also showing promising growth, albeit at a slower pace. In Latin America, Brazil and Mexico are leading the charge with enhanced healthcare initiatives. The Middle East & Africa are recognizing the need for improved cancer care, spurring investments in healthcare infrastructure and treatment options.

Key Trends and Drivers:

The Non-Small Cell Lung Cancer (NSCLC) market is experiencing transformative growth driven by advancements in targeted therapies and immunotherapies. Key trends include the development of personalized medicine approaches, enhancing treatment efficacy and patient outcomes. The integration of artificial intelligence in diagnostics is accelerating early detection and precision treatment planning, boosting market expansion. The rise of biomarker-driven therapies is another pivotal trend, allowing for more tailored and effective treatment regimens. Increasing investment in research and development is fostering innovation, leading to novel therapeutic options. The growing prevalence of NSCLC, coupled with an aging population, is significantly driving demand for advanced treatment solutions. Moreover, regulatory support and expedited approval processes for breakthrough therapies are facilitating faster market entry. Opportunities abound in emerging markets where healthcare infrastructure is improving, and awareness of lung cancer is rising. Companies focusing on strategic collaborations and expanding their product pipelines are well-positioned to capitalize on these dynamic market conditions.

Restraints and Challenges:

The NSCLC market encounters several significant restraints and challenges. One primary challenge is the high cost of targeted therapies and immunotherapies, which limits access for patients in low-income regions. These advanced treatments often come with prohibitive pricing, deterring widespread adoption and exacerbating healthcare inequalities. Moreover, the complexity of NSCLC's genetic landscape necessitates personalized treatment approaches, complicating the standardization of care protocols. This complexity also increases the burden on healthcare providers to stay updated with the latest developments and tailor treatments accordingly. Another challenge is the regulatory hurdles associated with the approval of new therapies, which can delay market entry and increase development costs. Additionally, the side effects associated with NSCLC treatments can be severe, impacting patient quality of life and adherence to therapy. Finally, the limited availability of comprehensive genomic testing in certain regions hampers the ability to implement precision medicine effectively, constraining optimal treatment outcomes.

Key Players:

BeiGene, Innovent Biologics, Zai Lab, Hutchmed, Array BioPharma, Blueprint Medicines, Mirati Therapeutics, Turning Point Therapeutics, Iovance Biotherapeutics, MacroGenics, Daiichi Sankyo, Eisai, Sumitomo Dainippon Pharma, Chugai Pharmaceutical, Kyowa Kirin

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Non-Small Cell Lung Cancer (NSCLC) Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Non-Small Cell Lung Cancer (NSCLC) Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Technology
  • 2.6 Key Highlights of the Market, by Application
  • 2.7 Key Highlights of the Market, by End User
  • 2.8 Key Highlights of the Market, by Stage
  • 2.9 Key Highlights of the Market, by Device
  • 2.10 Key Highlights of the Market, by Solutions
  • 2.11 Key Highlights of the Market, by Process
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Technology
  • 3.5 Market Attractiveness Analysis, by Application
  • 3.6 Market Attractiveness Analysis, by End User
  • 3.7 Market Attractiveness Analysis, by Stage
  • 3.8 Market Attractiveness Analysis, by Device
  • 3.9 Market Attractiveness Analysis, by Solutions
  • 3.10 Market Attractiveness Analysis, by Process
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: Non-Small Cell Lung Cancer (NSCLC) Market Outlook

  • 4.1 Non-Small Cell Lung Cancer (NSCLC) Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Non-Small Cell Lung Cancer (NSCLC) Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Non-Small Cell Lung Cancer (NSCLC) Market Size

  • 6.1 Non-Small Cell Lung Cancer (NSCLC) Market Size, by Value
  • 6.2 Non-Small Cell Lung Cancer (NSCLC) Market Size, by Volume

7: Non-Small Cell Lung Cancer (NSCLC) Market, by Type

  • 7.1 Market Overview
  • 7.2 Adenocarcinoma
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Squamous Cell Carcinoma
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Large Cell Carcinoma
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Others
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region

8: Non-Small Cell Lung Cancer (NSCLC) Market, by Product

  • 8.1 Market Overview
  • 8.2 Targeted Therapy Drugs
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Immunotherapy Drugs
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Chemotherapy Drugs
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Radiotherapy
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Others
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region

9: Non-Small Cell Lung Cancer (NSCLC) Market, by Technology

  • 9.1 Market Overview
  • 9.2 Biomarker Testing
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Genetic Testing
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Imaging Technologies
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Nanotechnology
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Others
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region

10: Non-Small Cell Lung Cancer (NSCLC) Market, by Application

  • 10.1 Market Overview
  • 10.2 First-Line Treatment
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Second-Line Treatment
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Maintenance Therapy
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Adjuvant Therapy
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Neoadjuvant Therapy
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Others
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region

11: Non-Small Cell Lung Cancer (NSCLC) Market, by End User

  • 11.1 Market Overview
  • 11.2 Hospitals
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Cancer Research Institutes
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Specialty Clinics
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Pharmaceutical Companies
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Others
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region

12: Non-Small Cell Lung Cancer (NSCLC) Market, by Stage

  • 12.1 Market Overview
  • 12.2 Stage I
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Stage II
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Stage III
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Stage IV
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Others
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region

13: Non-Small Cell Lung Cancer (NSCLC) Market, by Device

  • 13.1 Market Overview
  • 13.2 Biopsy Devices
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Diagnostic Imaging Systems
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Radiotherapy Equipment
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Others
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region

14: Non-Small Cell Lung Cancer (NSCLC) Market, by Solutions

  • 14.1 Market Overview
  • 14.2 Patient Management
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Clinical Trials
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Drug Development
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Others
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region

15: Non-Small Cell Lung Cancer (NSCLC) Market, by Process

  • 15.1 Market Overview
  • 15.2 Drug Discovery
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Clinical Development
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Regulatory Approval
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Commercialization
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region
  • 15.6 Others
    • 15.6.1 Key Market Trends & Opportunity Analysis
    • 15.6.2 Market Size and Forecast, by Region

16: Non-Small Cell Lung Cancer (NSCLC) Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Technology
    • 16.2.5 North America Market Size and Forecast, by Application
    • 16.2.6 North America Market Size and Forecast, by End User
    • 16.2.7 North America Market Size and Forecast, by Stage
    • 16.2.8 North America Market Size and Forecast, by Device
    • 16.2.9 North America Market Size and Forecast, by Solutions
    • 16.2.10 North America Market Size and Forecast, by Process
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Technology
      • 16.2.9.4 United States Market Size and Forecast, by Application
      • 16.2.9.5 United States Market Size and Forecast, by End User
      • 16.2.9.6 United States Market Size and Forecast, by Stage
      • 16.2.9.7 United States Market Size and Forecast, by Device
      • 16.2.9.8 United States Market Size and Forecast, by Solutions
      • 16.2.9.9 United States Market Size and Forecast, by Process
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Technology
      • 16.2.10.4 Canada Market Size and Forecast, by Application
      • 16.2.10.5 Canada Market Size and Forecast, by End User
      • 16.2.10.6 Canada Market Size and Forecast, by Stage
      • 16.2.10.7 Canada Market Size and Forecast, by Device
      • 16.2.10.8 Canada Market Size and Forecast, by Solutions
      • 16.2.10.9 Canada Market Size and Forecast, by Process
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Technology
    • 16.3.5 Europe Market Size and Forecast, by Application
    • 16.3.6 Europe Market Size and Forecast, by End User
    • 16.3.7 Europe Market Size and Forecast, by Stage
    • 16.3.8 Europe Market Size and Forecast, by Device
    • 16.3.9 Europe Market Size and Forecast, by Solutions
    • 16.3.10 Europe Market Size and Forecast, by Process
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.4 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.5 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.6 United Kingdom Market Size and Forecast, by Stage
      • 16.3.9.7 United Kingdom Market Size and Forecast, by Device
      • 16.3.9.8 United Kingdom Market Size and Forecast, by Solutions
      • 16.3.9.9 United Kingdom Market Size and Forecast, by Process
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Technology
      • 16.3.10.4 Germany Market Size and Forecast, by Application
      • 16.3.10.5 Germany Market Size and Forecast, by End User
      • 16.3.10.6 Germany Market Size and Forecast, by Stage
      • 16.3.10.7 Germany Market Size and Forecast, by Device
      • 16.3.10.8 Germany Market Size and Forecast, by Solutions
      • 16.3.10.9 Germany Market Size and Forecast, by Process
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Technology
      • 16.3.11.4 France Market Size and Forecast, by Application
      • 16.3.11.5 France Market Size and Forecast, by End User
      • 16.3.11.6 France Market Size and Forecast, by Stage
      • 16.3.11.7 France Market Size and Forecast, by Device
      • 16.3.11.8 France Market Size and Forecast, by Solutions
      • 16.3.11.9 France Market Size and Forecast, by Process
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Technology
      • 16.3.12.4 Spain Market Size and Forecast, by Application
      • 16.3.12.5 Spain Market Size and Forecast, by End User
      • 16.3.12.6 Spain Market Size and Forecast, by Stage
      • 16.3.12.7 Spain Market Size and Forecast, by Device
      • 16.3.12.8 Spain Market Size and Forecast, by Solutions
      • 16.3.12.9 Spain Market Size and Forecast, by Process
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Technology
      • 16.3.13.4 Italy Market Size and Forecast, by Application
      • 16.3.13.5 Italy Market Size and Forecast, by End User
      • 16.3.13.6 Italy Market Size and Forecast, by Stage
      • 16.3.13.7 Italy Market Size and Forecast, by Device
      • 16.3.13.8 Italy Market Size and Forecast, by Solutions
      • 16.3.13.9 Italy Market Size and Forecast, by Process
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.4 Netherlands Market Size and Forecast, by Application
      • 16.3.14.5 Netherlands Market Size and Forecast, by End User
      • 16.3.14.6 Netherlands Market Size and Forecast, by Stage
      • 16.3.14.7 Netherlands Market Size and Forecast, by Device
      • 16.3.14.8 Netherlands Market Size and Forecast, by Solutions
      • 16.3.14.9 Netherlands Market Size and Forecast, by Process
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Technology
      • 16.3.15.4 Sweden Market Size and Forecast, by Application
      • 16.3.15.5 Sweden Market Size and Forecast, by End User
      • 16.3.15.6 Sweden Market Size and Forecast, by Stage
      • 16.3.15.7 Sweden Market Size and Forecast, by Device
      • 16.3.15.8 Sweden Market Size and Forecast, by Solutions
      • 16.3.15.9 Sweden Market Size and Forecast, by Process
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.4 Switzerland Market Size and Forecast, by Application
      • 16.3.16.5 Switzerland Market Size and Forecast, by End User
      • 16.3.16.6 Switzerland Market Size and Forecast, by Stage
      • 16.3.16.7 Switzerland Market Size and Forecast, by Device
      • 16.3.16.8 Switzerland Market Size and Forecast, by Solutions
      • 16.3.16.9 Switzerland Market Size and Forecast, by Process
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Technology
      • 16.3.17.4 Denmark Market Size and Forecast, by Application
      • 16.3.17.5 Denmark Market Size and Forecast, by End User
      • 16.3.17.6 Denmark Market Size and Forecast, by Stage
      • 16.3.17.7 Denmark Market Size and Forecast, by Device
      • 16.3.17.8 Denmark Market Size and Forecast, by Solutions
      • 16.3.17.9 Denmark Market Size and Forecast, by Process
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Technology
      • 16.3.18.4 Finland Market Size and Forecast, by Application
      • 16.3.18.5 Finland Market Size and Forecast, by End User
      • 16.3.18.6 Finland Market Size and Forecast, by Stage
      • 16.3.18.7 Finland Market Size and Forecast, by Device
      • 16.3.18.8 Finland Market Size and Forecast, by Solutions
      • 16.3.18.9 Finland Market Size and Forecast, by Process
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Technology
      • 16.3.19.4 Russia Market Size and Forecast, by Application
      • 16.3.19.5 Russia Market Size and Forecast, by End User
      • 16.3.19.6 Russia Market Size and Forecast, by Stage
      • 16.3.19.7 Russia Market Size and Forecast, by Device
      • 16.3.19.8 Russia Market Size and Forecast, by Solutions
      • 16.3.19.9 Russia Market Size and Forecast, by Process
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by Stage
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by Device
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by Solutions
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by Process
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.5 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.6 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.7 Asia-Pacific Market Size and Forecast, by Stage
    • 16.4.8 Asia-Pacific Market Size and Forecast, by Device
    • 16.4.9 Asia-Pacific Market Size and Forecast, by Solutions
    • 16.4.10 Asia-Pacific Market Size and Forecast, by Process
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Technology
      • 16.4.9.4 China Market Size and Forecast, by Application
      • 16.4.9.5 China Market Size and Forecast, by End User
      • 16.4.9.6 China Market Size and Forecast, by Stage
      • 16.4.9.7 China Market Size and Forecast, by Device
      • 16.4.9.8 China Market Size and Forecast, by Solutions
      • 16.4.9.9 China Market Size and Forecast, by Process
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Technology
      • 16.4.10.4 India Market Size and Forecast, by Application
      • 16.4.10.5 India Market Size and Forecast, by End User
      • 16.4.10.6 India Market Size and Forecast, by Stage
      • 16.4.10.7 India Market Size and Forecast, by Device
      • 16.4.10.8 India Market Size and Forecast, by Solutions
      • 16.4.10.9 India Market Size and Forecast, by Process
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Technology
      • 16.4.11.4 Japan Market Size and Forecast, by Application
      • 16.4.11.5 Japan Market Size and Forecast, by End User
      • 16.4.11.6 Japan Market Size and Forecast, by Stage
      • 16.4.11.7 Japan Market Size and Forecast, by Device
      • 16.4.11.8 Japan Market Size and Forecast, by Solutions
      • 16.4.11.9 Japan Market Size and Forecast, by Process
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Technology
      • 16.4.12.4 South Korea Market Size and Forecast, by Application
      • 16.4.12.5 South Korea Market Size and Forecast, by End User
      • 16.4.12.6 South Korea Market Size and Forecast, by Stage
      • 16.4.12.7 South Korea Market Size and Forecast, by Device
      • 16.4.12.8 South Korea Market Size and Forecast, by Solutions
      • 16.4.12.9 South Korea Market Size and Forecast, by Process
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Technology
      • 16.4.13.4 Australia Market Size and Forecast, by Application
      • 16.4.13.5 Australia Market Size and Forecast, by End User
      • 16.4.13.6 Australia Market Size and Forecast, by Stage
      • 16.4.13.7 Australia Market Size and Forecast, by Device
      • 16.4.13.8 Australia Market Size and Forecast, by Solutions
      • 16.4.13.9 Australia Market Size and Forecast, by Process
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Technology
      • 16.4.14.4 Singapore Market Size and Forecast, by Application
      • 16.4.14.5 Singapore Market Size and Forecast, by End User
      • 16.4.14.6 Singapore Market Size and Forecast, by Stage
      • 16.4.14.7 Singapore Market Size and Forecast, by Device
      • 16.4.14.8 Singapore Market Size and Forecast, by Solutions
      • 16.4.14.9 Singapore Market Size and Forecast, by Process
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.4 Indonesia Market Size and Forecast, by Application
      • 16.4.15.5 Indonesia Market Size and Forecast, by End User
      • 16.4.15.6 Indonesia Market Size and Forecast, by Stage
      • 16.4.15.7 Indonesia Market Size and Forecast, by Device
      • 16.4.15.8 Indonesia Market Size and Forecast, by Solutions
      • 16.4.15.9 Indonesia Market Size and Forecast, by Process
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.4 Taiwan Market Size and Forecast, by Application
      • 16.4.16.5 Taiwan Market Size and Forecast, by End User
      • 16.4.16.6 Taiwan Market Size and Forecast, by Stage
      • 16.4.16.7 Taiwan Market Size and Forecast, by Device
      • 16.4.16.8 Taiwan Market Size and Forecast, by Solutions
      • 16.4.16.9 Taiwan Market Size and Forecast, by Process
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.4 Malaysia Market Size and Forecast, by Application
      • 16.4.17.5 Malaysia Market Size and Forecast, by End User
      • 16.4.17.6 Malaysia Market Size and Forecast, by Stage
      • 16.4.17.7 Malaysia Market Size and Forecast, by Device
      • 16.4.17.8 Malaysia Market Size and Forecast, by Solutions
      • 16.4.17.9 Malaysia Market Size and Forecast, by Process
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Device
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Solutions
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Technology
    • 16.5.5 Latin America Market Size and Forecast, by Application
    • 16.5.6 Latin America Market Size and Forecast, by End User
    • 16.5.7 Latin America Market Size and Forecast, by Stage
    • 16.5.8 Latin America Market Size and Forecast, by Device
    • 16.5.9 Latin America Market Size and Forecast, by Solutions
    • 16.5.10 Latin America Market Size and Forecast, by Process
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Technology
      • 16.5.9.4 Brazil Market Size and Forecast, by Application
      • 16.5.9.5 Brazil Market Size and Forecast, by End User
      • 16.5.9.6 Brazil Market Size and Forecast, by Stage
      • 16.5.9.7 Brazil Market Size and Forecast, by Device
      • 16.5.9.8 Brazil Market Size and Forecast, by Solutions
      • 16.5.9.9 Brazil Market Size and Forecast, by Process
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Technology
      • 16.5.10.4 Mexico Market Size and Forecast, by Application
      • 16.5.10.5 Mexico Market Size and Forecast, by End User
      • 16.5.10.6 Mexico Market Size and Forecast, by Stage
      • 16.5.10.7 Mexico Market Size and Forecast, by Device
      • 16.5.10.8 Mexico Market Size and Forecast, by Solutions
      • 16.5.10.9 Mexico Market Size and Forecast, by Process
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Technology
      • 16.5.11.4 Argentina Market Size and Forecast, by Application
      • 16.5.11.5 Argentina Market Size and Forecast, by End User
      • 16.5.11.6 Argentina Market Size and Forecast, by Stage
      • 16.5.11.7 Argentina Market Size and Forecast, by Device
      • 16.5.11.8 Argentina Market Size and Forecast, by Solutions
      • 16.5.11.9 Argentina Market Size and Forecast, by Process
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by Stage
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Device
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by Solutions
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Process
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.5 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.6 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.7 Middle East and Africa Market Size and Forecast, by Stage
    • 16.6.8 Middle East and Africa Market Size and Forecast, by Device
    • 16.6.9 Middle East and Africa Market Size and Forecast, by Solutions
    • 16.6.10 Middle East and Africa Market Size and Forecast, by Process
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by Stage
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Device
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by Solutions
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Process
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Technology
      • 16.6.10.4 UAE Market Size and Forecast, by Application
      • 16.6.10.5 UAE Market Size and Forecast, by End User
      • 16.6.10.6 UAE Market Size and Forecast, by Stage
      • 16.6.10.7 UAE Market Size and Forecast, by Device
      • 16.6.10.8 UAE Market Size and Forecast, by Solutions
      • 16.6.10.9 UAE Market Size and Forecast, by Process
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Technology
      • 16.6.11.4 South Africa Market Size and Forecast, by Application
      • 16.6.11.5 South Africa Market Size and Forecast, by End User
      • 16.6.11.6 South Africa Market Size and Forecast, by Stage
      • 16.6.11.7 South Africa Market Size and Forecast, by Device
      • 16.6.11.8 South Africa Market Size and Forecast, by Solutions
      • 16.6.11.9 South Africa Market Size and Forecast, by Process
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by Stage
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by Device
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by Solutions
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by Process
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 BeiGene
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 Innovent Biologics
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 Zai Lab
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 Hutchmed
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 Array BioPharma
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 Blueprint Medicines
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 Mirati Therapeutics
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 Turning Point Therapeutics
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 Iovance Biotherapeutics
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 MacroGenics
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 Daiichi Sankyo
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 Eisai
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 Sumitomo Dainippon Pharma
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 Chugai Pharmaceutical
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 Kyowa Kirin
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis